[144] Parker-Hannifin Corporation SEC Filing
Form 144 notice for Parker-Hannifin Corporation (PH). The filer proposes to sell 875 shares of common stock through UBS Financial Services on the NYSE, with an aggregate market value of 656,602. The proposed approximate sale date is 08/25/2025. The shares were acquired on 08/25/2025 by SAR Exercise from Parker Hannifin and payment was made by Wire. No securities of the issuer were reported sold by the selling person in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
- Detailed transaction disclosure including broker, acquisition method, and payment method supports Rule 144 compliance
- No sales reported by the selling person in the prior three months, simplifying aggregation considerations
- None.
Insights
TL;DR Routine Rule 144 notice for the sale of newly acquired shares via SAR exercise; appears procedural and compliant.
The filing documents a proposed sale under Rule 144 of 875 common shares through UBS Financial Services with an aggregate market value reported as 656,602 and an approximate sale date of 08/25/2025. The shares were acquired the same day by SAR exercise from Parker Hannifin and payment was wired. The filer indicates no sales in the prior three months and makes the customary representation about material nonpublic information. From a compliance perspective, the form contains the required transactional details and broker information needed to support Rule 144 resale conditions.
TL;DR Small, singular insider sale notice; not material to capital structure based on disclosed figures.
The notice reports a single proposed sale of 875 shares against 127,778,004 shares outstanding, executed through UBS on the NYSE with acquisition via SAR exercise dated 08/25/2025. The filing confirms no prior sales by the seller in the last three months. This is a routine disclosure of an intended resale under Rule 144 following a stock appreciation right exercise and does not include any additional financial results or corporate actions. There are no indicated encumbrances or complex consideration arrangements beyond a wire payment.